ATE92917T1 - Essigsaeureester des haloperidols und pharmazeutische zusammensetzungen davon. - Google Patents
Essigsaeureester des haloperidols und pharmazeutische zusammensetzungen davon.Info
- Publication number
- ATE92917T1 ATE92917T1 AT87307799T AT87307799T ATE92917T1 AT E92917 T1 ATE92917 T1 AT E92917T1 AT 87307799 T AT87307799 T AT 87307799T AT 87307799 T AT87307799 T AT 87307799T AT E92917 T1 ATE92917 T1 AT E92917T1
- Authority
- AT
- Austria
- Prior art keywords
- haloperidol
- pharmaceutical compositions
- acetate esters
- compounds
- tanone
- Prior art date
Links
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003878 haloperidol Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000002168 ethanoic acid esters Chemical class 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868621892A GB8621892D0 (en) | 1986-09-11 | 1986-09-11 | Organic compound |
| EP87307799A EP0260070B1 (de) | 1986-09-11 | 1987-09-03 | Essigsäureester des Haloperidols und pharmazeutische Zusammensetzungen davon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE92917T1 true ATE92917T1 (de) | 1993-08-15 |
Family
ID=10604021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87307799T ATE92917T1 (de) | 1986-09-11 | 1987-09-03 | Essigsaeureester des haloperidols und pharmazeutische zusammensetzungen davon. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4855307A (de) |
| EP (1) | EP0260070B1 (de) |
| JP (1) | JPS6377857A (de) |
| AT (1) | ATE92917T1 (de) |
| AU (1) | AU591334B2 (de) |
| DE (1) | DE3786966T2 (de) |
| DK (1) | DK166320C (de) |
| ES (1) | ES2058120T3 (de) |
| FI (1) | FI88155C (de) |
| GB (1) | GB8621892D0 (de) |
| IE (1) | IE60902B1 (de) |
| IL (1) | IL83819A (de) |
| NO (1) | NO169893C (de) |
| NZ (1) | NZ221711A (de) |
| PT (1) | PT85678B (de) |
| ZA (1) | ZA876819B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3742580C1 (de) * | 1987-12-16 | 1989-05-11 | Schaper & Bruemmer Gmbh | Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase |
| US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
| EP1787984B1 (de) * | 2000-03-06 | 2016-10-19 | Acadia Pharmaceuticals Inc. | Azacyclische verbindungen zur verwendung bei der behandlung von erkrankungen im zusammenhang mit serotonin |
| RU2002126554A (ru) * | 2000-03-06 | 2004-03-20 | Акадиа Фармасьютикалз, Инк. (Us) | Азациклические соединения для применения при лечении опосредованных серотонином заболеваний |
| WO2003057698A2 (en) | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Spiroazacyclic compounds as monoamine receptor modulators |
| CN100509804C (zh) | 2002-06-24 | 2009-07-08 | 阿卡蒂亚药品公司 | N-取代哌啶衍生物作为血清素受体试剂 |
| US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| PT1587789E (pt) | 2003-01-16 | 2008-12-16 | Acadia Pharm Inc | Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas |
| US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| JP4996467B2 (ja) | 2004-09-27 | 2012-08-08 | アカディア ファーマシューティカルズ インコーポレイテッド | Ｎ−（４−フルオロベンジル）−ｎ−（１−メチルピペリジン−４−イル）−ｎ’−（４−（２−メチルプロピルオキシ）フェニルメチル）カルバミド、並びにその酒石酸塩及び結晶形態の合成 |
| HRP20130713T1 (en) | 2007-03-19 | 2013-09-30 | Acadia Pharmaceuticals Inc. | Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| PL3325444T3 (pl) | 2015-07-20 | 2021-12-06 | Acadia Pharmaceuticals Inc. | Sposoby wytwarzania N-(4-fluorobenzylo)-N-(1-metylopiperydyn-4-ylo)-N'-(4-(2-metylopropyloksy)fenylometylo)karbamidu oraz jego soli winianowej i postaci polimorficznej C |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| EP3558311A1 (de) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin allein oder in kombination zur verwendung in der behandlung von morbus-alzheimer-psychose |
| WO2018200977A1 (en) | 2017-04-28 | 2018-11-01 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB895309A (en) * | 1959-11-18 | 1962-05-02 | Res Lab Dr C Janssen Nv | Pyrrolidine and piperidine derivatives |
| US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
| DE1695194A1 (de) * | 1966-07-11 | 1971-03-18 | Hoffmann La Roche | Verfahren zur Herstellung von Piperidinderivaten |
| US4070473A (en) * | 1973-01-26 | 1978-01-24 | Ab Ferrosan | Piperidino-butyrophenones |
| JPS568318A (en) * | 1979-06-28 | 1981-01-28 | Janssen Pharmaceutica Nv | Non oral long acting composition of haloperidol and bromperidol derivative |
-
1986
- 1986-09-11 GB GB868621892A patent/GB8621892D0/en active Pending
-
1987
- 1987-09-03 AT AT87307799T patent/ATE92917T1/de not_active IP Right Cessation
- 1987-09-03 DE DE87307799T patent/DE3786966T2/de not_active Expired - Lifetime
- 1987-09-03 IE IE236687A patent/IE60902B1/en not_active IP Right Cessation
- 1987-09-03 EP EP87307799A patent/EP0260070B1/de not_active Expired - Lifetime
- 1987-09-03 ES ES87307799T patent/ES2058120T3/es not_active Expired - Lifetime
- 1987-09-04 US US07/093,404 patent/US4855307A/en not_active Expired - Lifetime
- 1987-09-08 NZ NZ221711A patent/NZ221711A/xx unknown
- 1987-09-08 IL IL83819A patent/IL83819A/xx not_active IP Right Cessation
- 1987-09-10 PT PT85678A patent/PT85678B/pt not_active IP Right Cessation
- 1987-09-10 FI FI873924A patent/FI88155C/fi not_active IP Right Cessation
- 1987-09-10 NO NO873785A patent/NO169893C/no unknown
- 1987-09-10 AU AU78232/87A patent/AU591334B2/en not_active Ceased
- 1987-09-11 JP JP62226744A patent/JPS6377857A/ja active Pending
- 1987-09-11 DK DK479587A patent/DK166320C/da not_active IP Right Cessation
- 1987-09-11 ZA ZA876819A patent/ZA876819B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB8621892D0 (en) | 1986-10-15 |
| NO169893C (no) | 1992-08-19 |
| AU7823287A (en) | 1988-03-17 |
| ES2058120T3 (es) | 1994-11-01 |
| FI873924L (fi) | 1988-03-12 |
| PT85678A (en) | 1987-10-01 |
| NO169893B (no) | 1992-05-11 |
| PT85678B (pt) | 1990-05-31 |
| IE872366L (en) | 1988-03-11 |
| IE60902B1 (en) | 1994-08-24 |
| EP0260070B1 (de) | 1993-08-11 |
| ZA876819B (en) | 1988-06-29 |
| AU591334B2 (en) | 1989-11-30 |
| FI88155C (fi) | 1993-04-13 |
| FI88155B (fi) | 1992-12-31 |
| NO873785D0 (no) | 1987-09-10 |
| NO873785L (no) | 1988-03-14 |
| DE3786966T2 (de) | 1994-03-17 |
| DK166320C (da) | 1993-08-23 |
| JPS6377857A (ja) | 1988-04-08 |
| DK166320B (da) | 1993-04-05 |
| IL83819A (en) | 1992-02-16 |
| IL83819A0 (en) | 1988-02-29 |
| DK479587D0 (da) | 1987-09-11 |
| NZ221711A (en) | 1989-11-28 |
| EP0260070A1 (de) | 1988-03-16 |
| DE3786966D1 (de) | 1993-09-16 |
| US4855307A (en) | 1989-08-08 |
| DK479587A (da) | 1988-03-12 |
| FI873924A0 (fi) | 1987-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE92917T1 (de) | Essigsaeureester des haloperidols und pharmazeutische zusammensetzungen davon. | |
| ATE103914T1 (de) | Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen. | |
| ES2054919T3 (es) | Acidos y esteres 4-(quinolin-2-il-metoxi)fenilaceticos alfa-substituidos en caso dado. | |
| IL90435A (en) | 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| ES2168299T3 (es) | Composicion farmaceutica que contiene heparina, fragmentos de heparina o sus derivados en combinacion con esteres de glicerol. | |
| DK34289A (da) | Madlavnings/salatolie | |
| DE69122364D1 (de) | Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen | |
| HUT52374A (en) | Process for producing pharmaceutical compositions | |
| ATE287289T1 (de) | Rückfettende ester auf basis von capryl-alkohol und isostearinsäure | |
| ATE78693T1 (de) | Ein dideoxynukleosid enthaltendes arzneimittel. | |
| EP0191724A3 (de) | 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DK149888C (da) | Analogifremgangsmaade til fremstilling af 1-(1,3,4-oxadiazolyl-2-phenoxy)-3-(4-phenylpiperazinyl)-propan-2-oler eller fysiologisk acceptable syreadditionssalte heraf | |
| ATE90095T1 (de) | Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
| DE69007738D1 (de) | Haarbehandlungsmittel. | |
| NO911237D0 (no) | Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner. | |
| MX9200600A (es) | Medicamento que contiene lacidipina, para el tratamiento o prevencion de arteriosclerosis. | |
| SE8505801D0 (sv) | 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
| NO944788L (no) | Fenylsubstituerte 1,4-dihydropyridiner | |
| DE59006944D1 (de) | Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester. | |
| ATE4808T1 (de) | Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE111732T1 (de) | Verwendung von 1,4-dihydropyridinen zur herstellung eines arzneimittels, zur behandlung von neuropathien, die durch diabetes mellitus verursacht sind. | |
| FI885487L (fi) | Foerfarande foer framstaellning av asparaginsyra-4-(fenylmetyl)-ester. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |